So foil is now legal in the UK (since September 5th), needle programmes across the country are now (hopefully) stocking it and offering it as a possible tool for change or early engagement route for people who smoke rather than inject their drug of choice. So here's a bit of advice for those workers giving it out.
09 September 2014 | Injecting Advice
On 3 September, the Office for National Statistics released Deaths related to drug poisoning in England and Wales, 2013. The data relates to deaths registered in 2013 and shows a sharp rise in deaths as a consequence of drug misuse in England and Wales.In 2013, 1,957 drug misuse deaths were registered, up 20 per cent on the figure for 2012 (1,636).
04 September 2014 | DrugScope (press release)
Health workers in Cape Town have warned of a possible increase in drug overdoses and the spread of infectious diseases, including HIV, if the use of needles to inject drugs increases.
This comes as health workers have noticed drug users turning away from smoking towards injecting. In response, the TB/HIV Care Association (THCA) in Observatory are preparing to educate needle using drug users on the safe use of needles. Whereas once hardcore addicts chose to smoke their 'unga' on tinfoil and people who “spiked” the drug were shunned and looked down upon, this is no longer the rule.
02 September 2014 | Groundup
People walking past the pharmacy where volunteers chat with Olesya — an intravenous drug user with HIV — glare at the young woman, quickening their pace as they go. Others, many of them also young women, stop to accept the clean clean syringes, HIV tests and pregnancy tests being handed out as part of an outreach program to do the things that many specialists say authorities are not: acknowledge the fact that a full-blown HIV epidemic is becoming more and more of a reality each day.
20 August 2014 | The Moscow Times
Sovaldi, approved by the Food and Drug Administration (FDA) last year for the treatment of chronic hepatitis C (HCV), has a success rate better than 90 percent, and is ideal for use in opioid treatment programs (OTPs), yet payers are balking at covering it for patients who have a history of a substance use disorder (SUD), ADAW has learned.
14 August 2014 | Alcohol & Drug Abuse Weekly
“Maximizing the benefits of ART for key populations” grew out of discussions between the Key Affected Populations and Treatment as Prevention Working Groups of the International AIDS Society. The two groups agreed that given the rapidly changing treatment and prevention landscape in HIV, there was a need to consider a range of issues affecting treatment access, prevention choices, and the implications of new guidelines for key populations.
24 July 2014 | International AIDS Society
Australia could prove critical in convincing Russia to change laws preventing heroin addicts from accessing opiate treatment programs, the UN secretary general’s special envoy for Aids in eastern Europe and central Asia said.
24 July 2014 | The Guardian
People on opioid substitution therapy for drug addiction can be safely and effectively treated for hepatitis C (HCV) with an investigational combination of medications, researchers said here.
24 July 2014 | MedPage Today
Monday night’s episode of panel discussion juggernaut Q&A was always going to be important. Yet the show was arguably stolen by Indonesian Health Minister Nafsiah Mboi, who has faced considerable backlash in her home country as the chair of The Global Fund to Fight AIDS, Tuberculosis and Malaria.
23 July 2014 | The New Daily
We have found that it is not the individuals at risk of HIV infection who are hard to reach. It’s the politicians and policymakers who adopt ideological rather than evidence-based programs. But HIV researchers too seem to be hard to reach at times, failing to investigate political determinants of health, and the impact of laws, policies, and enforcement on HIV vulnerability and access to care.
23 July 2014 | Human Rights Watch